Literature DB >> 22465823

Interactions of two O-phosphorylresveratrol derivatives with model membranes.

Michele F M Sciacca1, Rosa Chillemi, Sebastiano Sciuto, Matteo Pappalardo, Carmelo La Rosa, Domenico Grasso, Danilo Milardi.   

Abstract

The hydrosoluble resveratrol derivative 3-O-phosphorylresveratrol was shown to be more cytotoxic against DU 145 prostate cancer cells than its analog 4'-O-phosphorylresveratrol. In an attempt to unveil the molecular determinants that lye at the root of their different biological effects, here we investigate the interactions of the two resveratrol derivatives with DMPC model membranes by using DSC, membrane permeation/poration assays and molecular dynamics. The results show that the 3-O-derivative interacts with DMPC membranes and diffuses across them. The 4'-O-derivative lies preferentially onto the surface of membrane. The MD simulations provide a molecular interpretation of the experiments and highlight that, in order to maximize the apolar interactions, the 3-O-derivative is embedded in the lipid hydrophobic region. This topographical position of the 3-O resveratrol analog perturbs the liquid-crystalline order of the lipid bilayer promoting membrane curvature and partial lipid loss from the vesicle. This finding reconciles with the lowering of the enthalpy of the lipid phase transition and the ability of the molecule to diffuse across membranes. The present data contribute to explain the different biological activity of the two molecules and evidence that membrane permeability is a key requirement for effective design of resveratrol derivatives to be used for therapeutic purposes.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22465823     DOI: 10.1016/j.abb.2012.03.022

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  3 in total

1.  Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer's disease and other tauopathies.

Authors:  Fulvio Florenzano; Corsetti Veronica; Gabriele Ciasca; Maria Teresa Ciotti; Anna Pittaluga; Gunedalina Olivero; Marco Feligioni; Filomena Iannuzzi; Valentina Latina; Michele Francesco Maria Sciacca; Alessandro Sinopoli; Danilo Milardi; Giuseppe Pappalardo; De Spirito Marco; Massimiliano Papi; Anna Atlante; Antonella Bobba; Antonella Borreca; Pietro Calissano; Giuseppina Amadoro
Journal:  Oncotarget       Date:  2017-04-22

2.  Phosphorylated resveratrol as a protein aggregation suppressor in vitro and in vivo.

Authors:  Johannes Mehringer; Juan Antonio Navarro; Didier Touraud; Stephan Schneuwly; Werner Kunz
Journal:  RSC Chem Biol       Date:  2022-01-04

3.  Resveratrol-based cinnamic ester hybrids: synthesis, characterization, and anti-inflammatory activity.

Authors:  Ban-Feng Ruan; Wei-Wei Ge; Hui-Jie Cheng; Hua-Jian Xu; Qing-Shan Li; Xin-Hua Liu
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.